1 / 1

Supplementary Figure 3

Supplementary Figure 3. a. iPrEC. Untreated. Untreated. Doxo (0,75 µM). DTX (10 nM). % ROS. % Apoptosis (Ann V+/PI- cells). b. iPrEC. -. -. -. -. -. -. +. +. +. +. +. +. c. NAC. NAC. EV. USP2a MUT. USP2a WT. Untreated. Untreated. Doxo (0,75 µM). Doxo

tyler-hill
Download Presentation

Supplementary Figure 3

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplementary Figure 3 a iPrEC Untreated Untreated Doxo (0,75 µM) DTX (10 nM) % ROS % Apoptosis (Ann V+/PI- cells) b iPrEC - - - - - - + + + + + + c NAC NAC EV USP2aMUT USP2aWT Untreated Untreated Doxo (0,75 µM) Doxo (0,75 µM) DTX (10 nM) DTX (10 nM) ROS generation Supplementary Figure 3 Involvement of the oxidative stress in the response of iPrEC cells to Doxo and DTX treatments. Flow cytometric evaluation of (a) ROS generation and (b) apoptosis, carried out in the drug-exposed iPrEC cells, previously loaded with NAC agent. (c) Analysis of ROS production performed in Doxo- and DTX-treated iPrEC transfectants.

More Related